Dosage forms & technologies
UPM develops and manufactures the full range of oral solid dosage forms, with formulation and processing capabilities that span immediate- and modified-release products.
Tablets & capsules
- Tablets — immediate-release and modified-release (matrix, delayed, extended, and sustained-release), orally disintegrating tablets, and coated tablets.
- Capsules — including coated pellets and particle coating for capsule fill.
Release profiles & powder processing
- Release profiles — immediate-release (IR) and modified-release (MR/ER) formulation design, including matrix and functional-coating approaches.
- Powder processing — granulation, fluid-bed processing, encapsulation, coating, and tablet compression.
From clinical supply to commercial production
UPM’s infrastructure spans the full lifecycle: preclinical and clinical trial material through Phase I, II and III, registration/validation batches, commercial-scale production, and post-approval (Phase IV) supply. This continuity lets sponsors keep one manufacturing partner from first-in-human through launch and beyond — reducing tech-transfer risk at the most fragile hand-off points.
Quality, compliance & containment
Regulatory registrations
- cGMP, FDA-registered facility.
- DEA-registered for controlled substances.
Containment & analytical support
- High-potency / containment handling.
- Analytical development, release, and stability testing supporting each program.
Packaging & lifecycle management
Bottle and blister packaging, serialization, labeling, and post-approval lifecycle support (site transfers, scale changes, and ongoing CMC maintenance).